Singapore markets open in 8 hours 45 minutes

Akari Therapeutics, Plc (CLA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.4100-0.0400 (-2.76%)
As of 08:10AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 11.76M
Enterprise value 8.19M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.96
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.47

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-60.60%
S&P500 52-week change 326.27%
52-week high 34.6400
52-week low 30.9450
50-day moving average 31.4467
200-day moving average 32.5516

Share statistics

Avg vol (3-month) 313
Avg vol (10-day) 3N/A
Shares outstanding 57.92M
Implied shares outstanding 6N/A
Float 89.56B
% held by insiders 12,017.91%
% held by institutions 11.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 317 Aug 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-115.51%
Return on equity (ttm)-1,281.43%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -16.8M
Net income avi to common (ttm)-10.01M
Diluted EPS (ttm)-1.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.85M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.95
Book value per share (mrq)-0.04

Cash flow statement

Operating cash flow (ttm)-16.43M
Levered free cash flow (ttm)-16.74M